Eli Lilly & Co.

pharmaceutical corporation

Based in DC

🤖

AI Overview

With $532K in lobbying spend across 8 quarterly filings, Eli Lilly & Co is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2019.

$532K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$264K
2019	$268K

Issues Lobbied

Health Issues Trade

Lobbying Firms

Guidepoststrategies, LLC

Lobbyists

Phil Cox Larissa Martin

Government Agencies Targeted

These are the government entities that Eli Lilly & Co. disclosed contacting in their lobbying filings.

Commerce, Dept of (DOC)Executive Office of the President (EOP)Office of the Vice President of the United StatesU.S. Trade Representative (USTR)Health & Human Services, Dept of (HHS)Office of Management & Budget (OMB)SENATE

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Trade

drug pricing, Japan - pricing reform internationally

drug pricing, Japan - pricing reform internationally NAFTA OECD Trade Committee

drug pricing

drug pricing NAFTA OECD Trade Committee